Verismo Therapeutics
0 followers
‌
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options.
Industries
+1
Headquarters
Employees
Links
Org chart
Bryan Kim
CEO / Co-founder
Bryan Kim
Collapse
Jacqueline Stief
Head, Quality & Compliance
Pavel Aprelev
Director Of Corporate Development / Start-up Member
Raymond Luke
Director, MSAT
Andrea Campanile
Vice President, Clinical Operations
Similar companies
ARS Pharmaceuticals
1 follower
Calico
6 followers
Synthekine
3 followers
Forge Biologics
2 followers
Colossal Biosciences
2 followers
Slingshot Biosciences
1 follower
Elicio Therapeutics
1 follower
Manifold Bio
2 followers
Amgen
187 followers
HotSpot Therapeutics
1 follower
Sunstone Therapies
1 follower
Discover companies